Publication Fadlyana E, Lancet Infect Dis, 2023
Primary outcome on the report: Evaluate the seropositive, seroconversion rate and geometric mean titres of IgG anti-S-RBD and neutralising antibodies 28 days after booster dose vaccination.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.